Work

Phase II trial of sequential dose-dense epirubicin/cyclophosphamide (E/C) followed by docetaxel/capecitabine (D/X) as adjuvant or neoadjuvant chemotherapy for patients with HER2-negative breast cancer (BC)

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.635

Authors: S. De la Cruz, J. M. Aramendia, J. Espinós, O. Fernandez-Hidalgo, M. Santisteban, L. Arbea, J. Aristu, C. Garran, R. Martinez-Monge, F. Martinez-Regueira, Y. Nieto

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590006061

Cites:

Cited by: 2

Related to: 10